AI Isn’t a Therapist, but Many Teens Are Treating It Like One
Clinicians have a responsibility to understand the risks posed by AI chatbots and to inform teen patients, their parents and caregivers about them.
Hospital Margins Fell This Summer Amid Outpatient Slowdown, Data Shows
Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall. The margin decrease was driven largely by a seasonal slowdown in elective surgeries and payer mix pressures.
Thatch Secures $108M, Reaches $1B Valuation
The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.
GSK Commits $750M to Get Chimagen’s Phase 1-Ready Drug for Multiple Myeloma
GSK is acquiring global rights to a T cell engager that Chimagen Biosciences developed to hit three targets. GSK believes this tri-specific approach could offer advantages over currently available drugs that hit two targets, but other big pharma companies are also developing trispecific antibodies.
The Real Bottleneck in U.S. Pharma Reshoring Isn’t Factories – It’s Talent
Pharma leaders must take a “construction crew” mindset and start treating workforce development in the same manner as they do critical infrastructure.